Gastroscope Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

Gastroscope Market Summary

Gastroscopes are endoscopic devices used to visualize the upper gastrointestinal tract, aiding in the diagnosis and treatment of conditions like gastritis and ulcers. The gastroscope industry is characterized by its critical role in minimally invasive diagnostics and therapeutics. Key trends include the development of high-definition imaging, single-use gastroscopes, and AI-integrated systems for enhanced visualization. The market is driven by rising gastrointestinal disorders, aging populations, and healthcare infrastructure growth, though it faces challenges from high costs, infection risks, and regulatory hurdles.

Market Size and Growth Forecast
The global Gastroscope market was valued at USD 16.5–28.7 billion in 2024, with an estimated CAGR of 6.5%–8.5% from 2025 to 2030, driven by hospital applications.

Regional Analysis
North America is projected to grow at a CAGR of 6.3%–8.3%, with the U.S. leading due to advanced healthcare systems. Trends focus on single-use gastroscopes.
Europe is expected to achieve a CAGR of 6.0%–8.0%, with Germany and the UK driving growth through diagnostic advancements. The region emphasizes high-definition imaging.
Asia Pacific is anticipated to record the highest growth at 7.0%–9.0%, led by China and Japan, where gastrointestinal disorders are rising. Trends include cost-effective solutions.
Rest of the World is expected to grow at a CAGR of 5.8%–7.8%, supported by healthcare modernization in Latin America.

Application Analysis
Hospitals are estimated to grow at a CAGR of 6.5%–8.5%, driven by diagnostic and therapeutic needs. Trends focus on AI-integrated gastroscopes.
Diagnostic imaging centers are projected to expand at a CAGR of 6.3%–8.3%, fueled by outpatient services. Innovations include high-definition systems.
Orthopedic clinics are expected to grow at a CAGR of 6.0%–8.0%, supported by specialized diagnostics. Developments include single-use devices.
Other applications, like ambulatory centers, are anticipated to grow at a CAGR of 5.8%–7.8%, with trends toward minimally invasive solutions.

Key Market Players
Olympus, based in Tokyo, Japan, produces gastroscopes with high-definition imaging for hospitals and clinics.
Fujifilm, headquartered in Tokyo, Japan, offers gastroscopes with advanced visualization technologies.
PENTAX Medical, located in Tokyo, Japan, supplies gastroscopes for diagnostic centers, focusing on ergonomic designs.
SonoScape Medical Corp., based in Shenzhen, China, manufactures gastroscopes for cost-effective diagnostics.
Shanghai Aohua, headquartered in Shanghai, China, provides gastroscopes for emerging markets, emphasizing affordability.

Porter’s Five Forces Analysis
● Threat of New Entrants: Low; high capital and regulatory barriers limit entry.
● Threat of Substitutes: Moderate; alternative diagnostics like CT compete, but gastroscopes’ precision maintains their edge.
● Buyer Power: Moderate; hospitals negotiate, but specialized devices limit leverage.
● Supplier Power: Moderate; imaging and material suppliers have some influence.
● Competitive Rivalry: High; players differentiate through imaging and single-use technologies.

Market Opportunities and Challenges
Opportunities
● Rising gastrointestinal disorders drive gastroscope adoption.
● Advancements in single-use and AI-integrated gastroscopes enhance market opportunities.
● Emerging markets in Asia Pacific offer growth potential due to healthcare expansion.
Challenges
● High costs of advanced gastroscopes limit adoption in smaller facilities.
● Infection risks from reusable devices increase regulatory scrutiny.
● Regulatory hurdles for medical devices complicate market entry.

Growth Trend Analysis
The Gastroscope market is growing steadily. On July 17, 2024, EvoEndo released the Model LE 85 Single-Use Gastroscope for sedation-free transnasal endoscopy. On August 15, 2024, Fiona Stanley Fremantle Hospitals Group expanded its digital pathways for gastroscopy units. On April 30, 2025, FUJIFILM launched the EG-840T and EG-840TP gastroscopes with enhanced visualization. On June 9, 2025, UCLH Private Healthcare launched a diagnostic endoscopy service, including gastroscopy. These align with a projected CAGR of 6.5%–8.5% through 2030.